US Patent Issued to TREFOIL THERAPEUTICS on April 14 for "Recombinant modified fibroblast growth factors and therapeutic uses thereof" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,756, issued on April 14, was assigned to TREFOIL THERAPEUTICS INC. (San Diego).

"Recombinant modified fibroblast growth factors and therapeutic uses thereof" was invented by David Eveleth (San Diego), Jennifer Jenkins-Eveleth (San Diego), Amuthakannan Subramaniam (San Diego) and Ralph Bradshaw (Encinitas, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are modified fibroblast growth factor (FGF) polypeptides, pharmaceutical compositions and medicaments that include such modified FGF polypeptides, and methods of using such modified FGF polypeptides to treat or prevent conditions that benefit from administration of FGFs."

The ...